Device Orthopedics/Orthopedic Surgery

Proven Gen-Flex Ps Knee System

Payments companies reported to CMS as associated with Proven Gen-Flex Ps Knee System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$13Kassociated payments (2023-2025)
20clinicians with associated payments
1company reporting

By year

2024 $13K

Payments reported as associated with Proven Gen-Flex Ps Knee System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $7,660
Adult Reconstructive Orthopaedic Surgery $4,467
Neurological Surgery $195
Orthopaedic Trauma $193

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Proven Gen-Flex Ps Knee System

These are the largest totals companies reported as associated with Proven Gen-Flex Ps Knee System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
George Chimento New Orleans, LA Orthopaedic Surgery $2,256.41
Dennis Pfisterer Teaneck, NJ Orthopaedic Surgery $1,667.55
Friedrich Boettner New York, NY Adult Reconstructive Orthopaedic Surgery $1,334.62
Alberto Carli New York, NY Adult Reconstructive Orthopaedic Surgery $1,256.06
Richard Steinfeld Vero Beach, FL Orthopaedic Surgery $1,024.28
Zackary Byrd New Albany, OH Orthopaedic Surgery $937.49
Stuart Mitchell Chapel Hill, NC Orthopaedic Surgery $807.48
Dustin Hambright Mount Pleasant, SC Adult Reconstructive Orthopaedic Surgery $752.40
William Lutes Kenosha, WI Adult Reconstructive Orthopaedic Surgery $616.76
Matthew Hepinstall New York, NY Orthopaedic Surgery $579.38

Prescribed Proven Gen-Flex Ps Knee System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.